HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

520.049

-14.807-2.77%

Number of Gainers:4

Number of Losers:25

Number of Flat:4

PE:- -

High:534.785

Open:534.750

Low:511.189

Close:534.856

Volume:28.35M

Turnover:790.11M

Market Cap:329.06B

Float Cap:294.58B

Loading ...

Several Pharmaceutical Stocks Open Higher in Morning Trading: Antengene-B Surges Over 5%, CanSino Biologics Rises More Than 3%

Hong Kong Stock Movers: Several Pharma Stocks Open Higher as Sector Tailwinds Mount; Novartis Bets Nearly $7.8 Billion on mRNA-TCE

NIO-SW Delivers 300,301 Vehicles in First Three Quarters, Up 49.2% Year-on-Year

Antengene to Present Preclinical Cos-TCE Platform Data at SITC 2026 Rapid Oral Session

Antengene-B Repurchases 93,000 Shares for HK$304,600 on October 2

ZYLOXTB Spends HK$1.1282 Million to Repurchase 53,000 Shares on October 2

Ascletis Pharma Presents Preclinical Data for Weight Loss Drug at European Conference

MT Newswires Live

Major Drugmakers Turn to China for Licensing Deals

Ascletis Pharma-B Reports Promising Preclinical Data for ASC36_35FDC at EASD 2026, Showing Potential for Monthly to Quarterly Dosing and Robust Weight Loss

Zhitong AH Premium Statistics for October 2: NE Electric Tops Premium List, CATL at Bottom

Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%

Akeso (SEHK:9926) Could Be 31% Undervalued As Phase III Trial Hits Key Goals

Simply Wall St.

Does Long Term Trial Data Change The Bull Case For RemeGen Stock (SEHK:9995)?

Simply Wall St.

October Golden Stock Picks from Brokerages Revealed, Covering Pharmaceuticals, Information Technology, and More; WuXi AppTec and Zhongji Innolight Receive the Most Recommendations (List)

AH Premium Statistics: October 1

Everest Medicines Stock In Focus After China Approval For CARDAMYST

Simply Wall St.

Two Active Equity Funds Double Returns Exceeding 110%! First Three Quarters Active Equity Fund Performance Rankings Released

Pre-Holiday Gains: Can This Strong Sector Keep Rising After the Break?

China Pharma Sector Divergence Deepens as Innovative Drug Leaders Ride BD Second Growth Curve

Guo Huaqing Steps Down as Non-Executive Director of CARsgen-B (02171)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK1574/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":520.049,"timestamp":1791360530318,"preClose":534.8557,"halted":0,"volume":28347278,"delay":0,"changeRate":-0.027684,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-14.806702,"latestTime":"10-07 16:00:00","open":534.75037,"high":534.78467,"low":511.18866,"amount":790109770,"amplitude":0.044117,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791336600000,1791345600000],[1791349200000,1791360000000]],"pbRate":3.979326,"peRate":176.925621,"turnoverRate":0.001047,"increases":4,"decrements":25,"flats":3,"marketCap":329063261872,"floatMarketCap":294579717944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":534.78467,"amplitude":0.044117,"preClose":534.8557,"low":511.18866,"pbRate":"3.979326","latestPrice":520.049,"volume":28347278,"delay":0,"open":534.75037,"prevYearClose":556.26263,"prevWeekClose":515.56,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":519.273,"twentyDayClose":518.573,"sixtyDayClose":497.867,"secType":"PLATE","market":"HK","turnoverRate":0.001047,"peRate":176.925621,"marketCap":329063261872,"floatMarketCap":294579717944,"timestamp":1791360530318,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":4,"down":25,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155981001","title":"Several Pharmaceutical Stocks Open Higher in Morning Trading: Antengene-B Surges Over 5%, CanSino Biologics Rises More Than 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155981001","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155981001?lang=en_us&edition=fundamental","pubTime":"2026-10-05 09:40","pubTimestamp":1791164415,"startTime":"0","endTime":"0","summary":"Several pharmaceutical stocks opened higher in morning trading. As of press time, Antengene-B (06996) climbed 5.26% to HK$3.5; CanSino Biologics (06185) gained 3.58% to HK$35.88; Joinn Laboratories (06127) rose 3.22% to HK$31.4; and GenScript Biotech (01548) advanced 2.93% to HK$45.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","06996","BK1515","BK1583","BK1574","06185","BK1191","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109146010","title":"Hong Kong Stock Movers: Several Pharma Stocks Open Higher as Sector Tailwinds Mount; Novartis Bets Nearly $7.8 Billion on mRNA-TCE","url":"https://stock-news.laohu8.com/highlight/detail?id=1109146010","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109146010?lang=en_us&edition=fundamental","pubTime":"2026-10-05 09:30","pubTimestamp":1791163817,"startTime":"0","endTime":"0","summary":"Several pharmaceutical stocks opened higher, with Antengene Corporation Limited (HKEX: 06996) up 5.26% at HK$3.5, CanSino Biologics Inc. (HKEX: 06185) up 3.58% at HK$35.88, Joinn Laboratories (China)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","LU0211331839.USD","IE0002141913.USD","NVS","IE00BJJMRZ35.SGD","MEDX","BK4532","LU0070302665.USD","BK4578","IE00BJT1NW94.SGD","BK1515","VXUS","IE00B2B36J28.USD","BK4007","BK4588","159938","IE0009355771.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","BK4585","LU0208291251.USD","PPH","KCAI","BK1574","IE00BFTCPJ56.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186229937","title":"NIO-SW Delivers 300,301 Vehicles in First Three Quarters, Up 49.2% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1186229937","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186229937?lang=en_us&edition=fundamental","pubTime":"2026-10-05 09:16","pubTimestamp":1791162974,"startTime":"0","endTime":"0","summary":"Major developments: MTR CORPORATION (ASX: 00066) has entered into a settlement deed with the government regarding the High Speed Rail Hong Kong Section and Shatin to Central Link project,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0197773160.USD","LU0630378692.HKD","03918","BK1587","BK1180","BK1588","LU0320764755.SGD","LU0029875118.USD","09866","LU0762540952.USD","XPEV","09973","LU2663582299.SGD","BK1236","LU0762542818.HKD","00066","IDRV","LU0672654166.SGD","LU0128522157.USD","BK1510","LU0762541174.USD","LU2506952253.HKD","LU1039395188.USD","LU0831093199.SGD","01876","SG9999001903.USD","00290","SG9999000459.SGD","BK1539","BK1119","NIO.SI","01021","09868","BK1147","BK1575","01672","BK1183","BK1578","LU0197773673.USD","BK1161","BK1521","BK1577","BK1601","LU0823437842.USD","LU0543330483.HKD","MTCPY","BK1172","BK1144","BK1574","LU0593848301.USD","LU0630378429.USD","LU1508157978.USD","BK1610","BK1604","BK1589","BK1515","NGCRY","02889","NIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672074404","title":"Antengene to Present Preclinical Cos-TCE Platform Data at SITC 2026 Rapid Oral Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2672074404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672074404?lang=en_us&edition=fundamental","pubTime":"2026-10-03 08:30","pubTimestamp":1790987421,"startTime":"0","endTime":"0","summary":"Antengene to present preclinical Cos-TCE platform data at SITC 2026 rapid oral sessionAntengene flagged new preclinical findings for its Cos-TCE immunotherapy platform, with results scheduled for pres","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261003:nNDLc85y1Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","06996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109244128","title":"Antengene-B Repurchases 93,000 Shares for HK$304,600 on October 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1109244128","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109244128?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:32","pubTimestamp":1790937140,"startTime":"0","endTime":"0","summary":"Antengene-B (06996) announced that it repurchased 93,000 shares for HK$304,600 on October 2, 2026.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06996","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163085957","title":"ZYLOXTB Spends HK$1.1282 Million to Repurchase 53,000 Shares on October 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1163085957","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163085957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:22","pubTimestamp":1790936529,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced that on October 2, 2026, the company spent HK$1.1282 million to repurchase 53,000 shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02190","BK1574","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715999","title":"Ascletis Pharma Presents Preclinical Data for Weight Loss Drug at European Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715999","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715999?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:58","pubTimestamp":1790935122,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it presented key preclinical data for its ASC36_35FDC in a short oral discussion at the 62nd European Association for the Study of Diabetes  Annual Meeting in Milan, Italy.The data showed promising activity in bodyweight reduction, appetite suppression, formulation stability and pharmacokinetic properties, the filing said.The conference began Sept. 28 and will conclude Oct. 2.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EPV","01672","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","LU2476274720.SGD","LU0225771236.USD","LU2646069778.SGD","LU2023250843.SGD","IE00B7KXQ091.USD","LU1236620750.USD","LU0708994859.HKD","LU2461242641.AUD","LU0306807586.USD","LU1244550221.USD","LU1226287792.SGD","LU0198837287.USD","LU1670627923.USD","LU0079474960.USD","LU2133065610.SGD","LU1831875114.USD","LU2355687059.USD","LU0672654240.SGD","LU2539964713.USD","LU0171293334.USD","LU0526926950.USD","LU2213496289.HKD","LU2242644610.SGD","IE000WAW04H5.SGD","LU1084165304.USD","IE00B19Z3581.USD","SG9999001176.SGD","IE00BKPKM643.USD","LU0256863902.USD","LU1670710588.SGD","LU1127390331.HKD","LU1153584641.USD","LU1670710661.SGD","LU2023251221.USD","PJP","BK4535","LU1720051017.SGD","LU0787776722.HKD","LU0997586432.USD","LU1066051498.USD","LU0792757196.USD","HK0000165453.HKD","LU1400636574.HKD","LU2106854487.HKD","LU1868836914.USD","LU1116320901.HKD","LU2495084118.USD","LU0310799852.SGD","LU0158827948.USD","LU2129689431.USD","LU2476274308.USD","LU0575583348.USD","THNR","LU0320765992.SGD","LU2552382132.HKD","LU0047473722.EUR","LLYZ","BMY","LU2168564495.EUR","LU0109981661.USD","LU2462591350.SGD","HCM","IBB","BK0060","IE000M9KFDE8.USD","IE00B1XK9C88.USD","LU0965509010.AUD","LU0265550946.USD","LU0965509101.SGD","LU1261432733.SGD","LU0244354667.USD","BK5011","IE00B031HY20.USD","LU0971552673.USD","LU1481599808.USD","LU0094547139.USD","LU0029864427.USD","LU0912757837.SGD","SG9999015341.SGD","LU0211326755.USD","LU1064131003.USD","LU2237443978.SGD","SG9999015986.USD","LU2289578879.USD","LU1226288170.HKD","BK4581","LU0069063385.USD","LU1244550494.USD","LU1989772840.SGD","LU0972486137.USD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU0920840948.USD","GLAM","LU0314109678.HKD","LU1023059063.AUD","LU0971552830.HKD","LU0784384876.USD","ABBV","LU0889565916.HKD","LU2111349929.HKD","LLYX","IE00BZ08YS42.EUR","LU0061475181.USD","BK1588","LU1037948897.HKD","LU1019634622.SGD","LU0238689110.USD","NVOX","LU0689626769.HKD","LU1883839398.USD","LU2129689605.HKD","600276","LU0306806265.USD","LU2114397693.USD","LU2746668461.USD","LU0965508806.USD","LU0963555726.SGD","LU0097036916.USD","LU0395794307.EUR","LU1280957306.USD","LU1255011170.USD","IE00BQJZX424.USD","LU0006306889.USD","LU0310800965.SGD","LU0857590862.USD","LU1929549753.HKD","LLY","LU1066053197.SGD","LU0634319403.HKD","LU1997245094.SGD","LU1226287875.USD","LU1273509221.SGD","NVO","LU0154236417.USD","LU1003076772.USD","LU0980610538.SGD","SMMT","LU0463099449.HKD","SG9999015978.USD","LU0882574055.USD","LU1032466523.USD","LU0353189680.USD","LU0234570918.USD","LU2433249047.HKD","LU2211815571.USD","GDOC","LU2028103732.USD","LU2129689514.USD","IE00BN29S564.USD","LU1201861249.SGD","LU1629891620.HKD","LU0640478417.SGD","BK4585","LU0348825331.USD","LU1670756490.USD","LU2324357040.USD","LU2491049909.HKD","SG9999001440.SGD","LU1732800096.USD","LU2488822045.USD","LU0211328371.USD","BK1583","LU1699723380.USD","LU1670711123.USD","BK1191","BK1161","BK4533","LU2417539215.USD","LU1061106388.HKD","IE00B5MMRT66.SGD","IE00BKDWB100.SGD","LU0070302665.USD","LU1894683264.USD","LU0315179316.USD","LU0957799991.USD","LU1496350171.SGD","LU2362541513.USD","LU1863844749.USD","LU0158827781.USD","SG9999014559.SGD","BK4139","LU1934455277.USD","LU0823399737.USD","LU1989771016.USD","LU0949170426.SGD","MHIP","LU2125154778.USD","BK4534","LU1839511570.USD","LU0072461881.USD","LU0321505868.SGD","LU0385154629.USD","LU1226287529.USD","LU1226288253.USD","03165","LU1807302812.USD","IE0004445015.USD","LU2237438978.USD","LU2264538146.SGD","LU1820825898.SGD","LU1988902786.USD","BK4516","LU0823416689.USD","LU1035777561.USD","LU2580892862.HKD","LU2237443895.HKD","LU0784383803.USD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","NVOH","LU2148510915.USD","IE0034235071.USD","LU0096364046.USD","LU0868494617.USD","LU0162691827.USD","LU0960981461.USD","LU1720051108.HKD","ELIL","IE00B3M56506.USD","LU1228905037.USD","LU2293690249.USD","LU0985320562.USD","NVS","LU0345770993.USD","LU1267930730.SGD","LU1037948541.HKD","LU0997586515.USD","CANC","IE0001KFT4U8.USD","IE00BLSP4239.USD","LU0471298777.SGD","LU1232071149.USD","01801","TRUH","LU0098860793.USD","MEDI","IE00BFTCPJ56.SGD","IE00B543WZ88.USD","SG9999003800.SGD","LU1997245177.USD","LU0432979614.USD","VHT","IE00BFSS7M15.SGD","LU0417516571.SGD","LU1941712348.USD","IHE","LU2236285917.USD","LU0077335932.USD","LU1960683339.HKD","LU1585245621.USD","IE00BWDBJ516.SGD","02096","LU0861579265.USD","LU0067412154.USD","LU0174119429.USD","LU1997244956.HKD","LU0122379950.USD","LU0267386448.USD","PAWZ","BK4551","LU1035773651.USD","LU1804176565.USD","IE000MB6IJN5.SGD","LU2168564222.USD","BK1574","LU0057025933.USD","LU2293690082.USD","IE00BSNM7G36.USD","IE00BDGV0183.EUR","LU1267930573.SGD","LU2471134952.CNY","LU0348784397.USD","IE000F7OJYX1.SGD","LU2602419157.SGD","IE00BKPKM429.USD","LU0203201768.USD","MRK","LU0456855351.SGD","TMED","LU2750360641.GBP","LU0784385170.HKD","LU0128525689.USD","SGXZ99366536.SGD","LU1983299246.USD","LU0417516738.SGD","LU0320765059.SGD","IE000SO60NU8.SGD","LU0326950275.SGD","IE00BFXG1179.USD","LU0795875169.SGD","PFE","SG9999014542.SGD","LU0011850046.USD","LU0225284248.USD","LU0502904849.HKD","ILDR","SG9999018865.SGD","LU0880133367.SGD","LU0211327993.USD","LU0477156953.USD","LU0920783379.SGD","IE0034235188.USD","LU2462157665.USD","03692","IE00BJJMRY28.SGD","LU0868494708.USD","LU1069347547.HKD","LU0708995401.HKD","SG9999014906.USD","LU0943347566.SGD","LU2456880835.USD","BK1587","LU2112291526.USD","LU1941712264.USD","IE00BZ08YR35.GBP","IE00B4JS1V06.HKD","LU1951186391.HKD","LU1267930227.SGD","LU0047473722.SGD","LU1868837136.USD","LU0472753341.HKD","LU2089283258.USD","LU0256863811.USD","LU0405327494.USD","LU0511384066.AUD","LU2552382058.USD","OZEM","LU2168563687.JPY","BMED","IYH","LU1487256676.USD","LU0320765489.SGD","LU2471134796.USD","IE00BVYPNV92.GBP","LU2362540622.SGD","LU2362541273.HKD","LU0820561818.USD","LU1116320737.USD","BK4007","LU0417516902.SGD","LU2471134523.USD","IE00BGHQF631.EUR","PPH","LU1064130708.USD","LU2746668974.SGD","LU0607220059.USD","LU2125909247.SGD","IE0008368742.USD","LU1917777945.USD","LU0052756011.USD","LU0496365809.HKD","LU0561508036.HKD","688506","LU1989772923.USD","LU2756315664.SGD","IE0008369823.USD","IE00BN8TJ469.HKD","LU0965509283.SGD","LU1046234339.USD","IE00BK4W5M84.HKD","LU2089284900.SGD","LU0540923850.HKD","LU2491050154.USD","LU0545562505.USD","LU0320765646.SGD","IE00BBT3K403.USD","LU0348766576.USD","LU0390134368.USD","LU1548497426.USD","09926","LU0648001328.SGD","IE00BJLML261.HKD","LU1145028129.USD","LU0265550359.USD","LU1481600234.SGD","LU1979441026.SGD","LU1051770623.HKD","LU2087621335.USD","IE00B775H168.HKD","LU0348735423.USD","LU1814569148.SGD","IE00BWXC8680.SGD","LU2271345857.HKD","00013","SGXZ57979304.SGD","LU2491050071.SGD","ELIS","LU0266013472.USD","LU1328277881.USD","LU2778985437.USD","IE000BZT7R73.USD","LU0661504455.SGD","LU1046248800.SGD","LU0106261372.USD","LU1152091754.HKD","LU2125909593.SGD","FHLC","LU1066051225.USD","01530","LU2242652126.USD","LU1323610961.USD","GB00BDT5M118.USD","LU0969580561.USD","LU0161305163.EUR","LU1880407215.USD","09995","LU2357305700.SGD","LU0072913022.USD","RHHBY","SGXZ51526630.SGD","LU1781817850.SGD","LU1196032939.SGD","03933","IE00BJJMRX11.SGD","BK4550","LU1170363599.USD","LU1069344957.HKD","LU1868837300.USD","SG9999017495.SGD","LU2328871848.SGD","LU1309081286.SGD","LU1732799900.SGD","IBBQ","LU1057294990.SGD","IE0002270589.USD","LU1066051811.HKD","LU0203345920.USD","LU0345770308.USD","LU0354030438.USD","SG9999001176.USD","LU0124676726.USD","LU0348783233.USD","LU1104425308.USD","LU1152091168.USD","LU1236620834.HKD","LU2237443465.HKD","LLII","LU0823434740.USD","LU0316494557.USD","LU0348827113.USD","IE0009355771.USD","LU2097828714.EUR","LU1302929846.USD","LU2023250504.SGD","LU2125154935.USD","LU2265009873.SGD","IE00BLSP4452.SGD","LU0208291251.USD","LU0471298694.HKD","LU0757432116.USD","BK0028","SG9999014575.USD","BK0188","LU1267930490.SGD","LU1655091616.SGD","01093","LU2360032135.SGD","KURE","LU0289739699.SGD","LU1098665638.USD","IXJ","LU2279689827.SGD","LU2237443622.USD","LU1993786604.SGD","LU1328615791.USD","IE00BJT1NW94.SGD","LU0354030511.USD","LU1301847155.USD","BK4532","LU0289739343.SGD","LU2361045086.USD","SG9999014567.USD","LU1670711040.USD","01276","LU1868836757.USD","LU1015430645.USD","LU1551013342.USD","IE00BZ08YT58.USD","LU0795875086.SGD","LU0323591593.USD","LU2552382215.SGD","LU1078025761.USD","BK1593","RXL","LU0203202063.USD","LU0726765562.USD","LU0133085943.USD","LU0964807845.USD","LU0738911758.USD","IE0002141913.USD","LU1228905540.USD","LU0058720904.USD","LU1691799644.USD","BK1521","SG9999014880.SGD","BK4559","SG9999015952.SGD","LU1064131342.USD","BK4592","SG9999002224.SGD","LU1645745479.HKD","IE00B42XCP33.USD","BK1589","LU1670628061.USD","LU1580142542.USD","LU0114720955.EUR","LU0820562030.AUD","LU0942090050.USD","LU1019632923.USD","LU0345777659.USD","IE00BVYPNW00.USD","AGNG","IE00B1BXHZ80.USD","LU1496350502.SGD","IE0005OL40V9.USD","LU1093756168.USD","SGXZ31699556.SGD","LU0887340254.USD","BK0012","LU1974910355.USD","NVOC","LU1267930813.SGD","LU1119994496.HKD","SG9999013999.USD","LU2168564149.EUR","LU1961090484.USD","TBXU","LU0348767384.USD","IE0004445239.USD","LU0557290698.USD","LU1003077747.HKD","LU0889566641.SGD","BK0196","LU1868836591.USD","LU0553294199.USD","LU0109394709.USD","LU1153585028.USD","LU2039709279.SGD","LU0211326839.USD","AZN.UK","IE00BZ1G4Q59.USD","LU2357627491.SGD","BK4568","SG9999014898.SGD","LU2168564065.EUR","SG9999002232.USD","LU0149534421.HKD","LU1355424745.HKD","LU0130102774.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1162221912.USD","WDNA","LU0310800379.SGD","LU0455707207.USD","LU0171276677.USD","LU1571399168.USD","LU1934455194.USD","LU2750360997.AUD","LU0345777147.USD","LU2237443382.USD","BK4578","LU0784385840.USD","LU1244550577.SGD","LU2097828631.EUR","LU0321505439.SGD","LU0859254822.USD","LU2347655073.USD","LU0499090636.EUR","LU0964806797.USD","LU1188198961.HKD","LU0289961442.SGD","LU2063271972.USD","LU2242646821.SGD","LU0501845795.SGD","LU0545039389.USD","LU0689472784.USD","BNTX","LU2087625088.SGD","LU1366192091.USD","LU2097828805.USD","BK4588","IE00B3T34201.USD","LU1718418525.SGD","SG9999018857.SGD","LU0237698245.USD","LU0985481810.HKD","SG9999014914.USD","IE00BPRC5H50.USD","BK1515","JDOC","BK4566","IE00B2B36J28.USD","LU1863844665.USD","LU2468319806.SGD","LU1880407132.USD","LU3187612489.SGD","REGN","LU0820561909.HKD","LU1551013425.SGD","LU1202635105.USD","LU1720050803.USD","LU1969619763.USD","LU1291159041.SGD","LU1923622614.USD","LU2361044865.SGD","LU1829250122.USD","LU2097828557.USD","LU2237443549.SGD","LU0976567544.SGD","BK0239","HRTS","LU2089984988.USD","LU2399975544.HKD","LU0053666078.USD","BK4548","SG9999004220.SGD","688331","LU1813983027.USD","LU0211331839.USD","LU0170899867.USD","LU1035775433.USD","XLV","LU0417517546.SGD","LU0140636845.USD","LU0882574139.USD","LU0128525929.USD","LU2580892789.USD","LU2596442595.SGD","LU1623119135.USD","LU1794554557.SGD","BBH","LU0405327148.USD","LU2091194634.USD","LU1074936037.SGD","LU1093756325.SGD","LU2097828474.EUR","LU1400636657.SGD","LU0683600562.USD","LU0889565080.SGD","LU0786609619.USD","LU0109391861.USD","LU0353189763.USD","LU1064927863.SGD","FTXH","IE0000B7K699.USD","LU2360106947.USD","LU1400636491.USD","LU0210536198.USD","LU0130517989.USD","LU0225283273.USD","LU0827474353.SGD","LU0987226296.USD","SG9999015358.SGD","LU0466842654.USD","LU2347655156.SGD","IE00BFSS8Q28.SGD","MEDX","LU2023250330.USD","LU0823434583.USD","LU0949170772.SGD","LU2756315318.SGD","LU1934455863.HKD","LU2896262040.SGD","CURE","LU2361044949.HKD","LU2108987350.USD","LU2471134879.HKD","SGXZ81514606.USD","IE00B3PB1722.GBP","BK4599","IE00BKVL7J92.USD","LU1008478684.HKD","SG9999015945.SGD","GSK.UK","LU1712237335.SGD","LU1430594728.SGD","LU1894683348.USD","IE00BK4W5L77.USD","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123655557","title":"Ascletis Pharma-B Reports Promising Preclinical Data for ASC36_35FDC at EASD 2026, Showing Potential for Monthly to Quarterly Dosing and Robust Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1123655557","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123655557?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:02","pubTimestamp":1790931742,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) has announced key preclinical data for ASC36_35FDC (a fixed-dose combination of ASC36 and ASC35), which was presented at the 62nd Annual Meeting of the European Association...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK1574","BK1191","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196851687","title":"Zhitong AH Premium Statistics for October 2: NE Electric Tops Premium List, CATL at Bottom","url":"https://stock-news.laohu8.com/highlight/detail?id=1196851687","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196851687?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:23","pubTimestamp":1790929409,"startTime":"0","endTime":"0","summary":"According to data compiled by Zhitong Financial, as of the close on October 2, NE ELECTRIC (00042), Zhejiang Shibao (01057), and Holly Futures (03678) claimed the top three spots for AH premium...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091168.USD","LU0052750758.USD","LU1961090484.USD","LU0886674414.USD","BK1149","LU2097828474.EUR","LU0328353924.USD","LU0871576103.HKD","BK1122","LU0469268626.HKD","02827","BK1144","LU2476274720.SGD","LU0326950275.SGD","82822","LU1048596156.SGD","03143","LU0327786744.USD","BK1249","LU1008478684.HKD","LU2476274308.USD","LU0561508036.HKD","BK1515","BK1190","BK1505","BK1521","03130","LU1813983027.USD","LU0384037296.USD","LU0214875030.USD","LU0348788117.USD","03188","LU0572944931.SGD","LU0456854461.SGD","LU0620787316.HKD","LU0229945570.USD","LU0823426308.USD","LU1366334651.USD","LU1719994722.HKD","02701","01138","82846","IE00B3M56506.USD","02846","LU2177674079.SGD","LU0417516738.SGD","LU1105468828.SGD","BK1530","LU0456846285.SGD","HK0000352382.USD","LU0051755006.USD","HK0000352291.HKD","LU0266512473.USD","LU2097828631.EUR","BK1533","LU0979878070.USD","BK1574","LU0329678337.USD","BK1507","LU0315179316.USD","LU0269904917.USD","00042","BK1231","LU0449509016.USD","LU1481107354.HKD","LU2039709279.SGD","LU0823426480.USD","LU1152091754.HKD","IE0008369823.USD","LU2097828805.USD","02245","LU0880133367.SGD","LU0737861772.HKD","LU1282649141.HKD","LU1688375341.USD","399300","LU0039217434.USD","LU0048580855.USD","BK1166","IE00BGHQDM52.EUR","LU0228659784.USD","LU0348825331.USD","02822","03968","LU1769817096.USD","LU0348805143.USD","07233","LU0543330483.HKD","BK1141","BK1202","BK1183","IE00BVYPNP33.GBP","LU0140636845.USD","LU2097828714.EUR","01349","SG9999011746.SGD","LU0708995583.HKD","LU0828238088.HKD","BK1191","IE00B5MMRT66.SGD","LU0488056044.USD","LU1064131342.USD","IE00BMCWC346.EUR","BK1116","BK1610","LU0165289439.USD","LU0348767384.USD","LU1720050803.USD","BK1130","LU0173614495.USD","LU1794554557.SGD","06821","LU0791591158.USD","LU1242518857.USD","LU0128522157.USD","LU1303224171.USD","LU0164939612.USD","IE00B031HY20.USD","01108","LU2778985437.USD","IE0032431581.USD","LU2264538146.SGD","BK1223","00553","LU1807302812.USD","LU1282649067.USD","03308","LU1880383440.USD","BK1562","00991","LU2097828557.USD","LU0828237510.HKD","LU0307460666.USD","LU0082770016.SGD","BK1198","09927","LU0348735423.USD","SG9999014674.SGD","LU2045819591.USD","BK1193","BK1594","IE00B29SXG58.USD","09976","HK0001040168.HKD","IE00B031J352.USD","IE0034224299.USD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU1328277881.USD","HK0000320223.HKD","LU0149721374.USD","LU0918141705.HKD","LU1880383366.USD","LU1244550494.USD","LU0061477393.USD","BK1576","LU0516422366.SGD","BK1237","LU0314109678.HKD","LU0345780521.USD","LU0320764599.SGD","LU1206782309.USD","LU2242644610.SGD","LU0455707207.USD","LU0640798160.USD","LU0106959298.USD","LU1251922891.USD","LU0890818403.SGD","00699","BK1523","LU0791590937.USD","LU1224709979.USD","BK1119","LU2399975544.HKD","LU0502904849.HKD","02218","LU0345780281.USD","LU2125910500.SGD","BK1544","LU1808992512.USD","LU1366334578.USD","01812","LU0163747925.USD","02338","LU0329678170.USD","LU0096374516.USD","02475","LU0797268264.HKD","BK1147","01057","LU0359201885.HKD","06185","LU1255011170.USD","LU0348827113.USD","LU0029875118.USD","03328","02865","LU1770034418.SGD","LU0828237940.HKD","LU1115378108.SGD","LU0672654166.SGD","BK1554","82843","BK1535","LU0117841782.USD","BK1564","LU0588546209.SGD","LU0320764755.SGD","HK0000306701.USD","83188","LU1769817179.HKD","BK1163","LU0501845795.SGD","SG9999001093.SGD","IE00B0169L03.USD","LU1244550577.SGD","LU0231483743.USD","LU1675838814.USD","LU0370786039.SGD","LU1282648689.USD","LU0516422952.EUR","02899","LU2008162690.USD","82823","LU1655091616.SGD","HK0001040143.USD","BK1105","LU0067412154.USD","BK1592","06869","LU0868486357.SGD","02843","00811","LU0516422440.USD","EWH","LU1188198961.HKD","LU1023057109.AUD","LU0516423091.SGD","BK1125","LU0348816934.USD","LU0456827905.SGD","LU1046422090.SGD","LU1831875114.USD","BK1522","06127","LU0348766576.USD","BK1161","HK0000320264.USD","02823","LU0431992006.USD","LU0211977185.USD","LU0918141887.USD","BK1506","LU0593848301.USD","IE00BVYPNQ40.USD","BK1171","BK1583","BK1181","LU0540923850.HKD","LU1226287529.USD","LU0043850808.USD","LU0543330566.HKD","LU0531971595.HKD","LU2226246903.HKD","LU0359201612.USD","159982","IE0008368742.USD","LU1993786604.SGD","BK1546","03200","LU0266512127.USD","LU0254981946.USD","LU0106252389.USD","03678","LU0821914370.USD","HK0000306685.HKD","LU0516423174.USD","IE00BF5LJ272.USD","LU0737861699.HKD","SG9999001226.SGD","LU1988902786.USD","LU1242518931.SGD","IE0031814852.USD","LU0359202008.SGD","LU0463099449.HKD","LU0049853897.USD","LU1960683339.HKD","LU1244550221.USD","LU0228367735.SGD","BK1551","03986","LU0634319403.HKD","LU0862451753.SGD","LU1282649810.SGD","IE00BZ08YR35.GBP","83130","02359","LU2394011477.USD","LU1504937902.USD","LU0607220059.USD","LU0417516902.SGD","LU0287142896.SGD","02691","LU0149534421.HKD","LU0082770016.USD","LU0164880469.USD","LU0072913022.USD","00300","SG9999004220.SGD","01033","LU0244354667.USD","SG9999006597.SGD","BK1514","LU0589944569.HKD","LU0348814723.USD","03750","00638","SG9999002463.SGD","LU2294711473.HKD","LU0531970944.HKD","LU0210526637.USD","LU0164865239.USD","IE00B543WZ88.USD","IE00BYV24P56.USD","LU3063872942.SGD","LU0648948544.HKD","BK1170","SG9999002828.SGD","LU0181495838.USD","LU1211504680.USD","LU0509642566.USD","BK1214","BK1560"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166541763","title":"Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166541763","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166541763?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:52","pubTimestamp":1790927535,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks broadly retreated, with InnoCare Pharma (09969) falling 8.38% to HK$13.55, RemeGen (09995) dropping 5.71% to HK$72.7, and 3SBio (01530) declining 4.95% to HK$15.75 as...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LU2148510915.USD","BK4588","HK0000165453.HKD","159992","LU1064131003.USD","BK4585","09995","01530","BK1161","LU2488822045.USD","LU2328871848.SGD","MEDX","LU1969619763.USD","09969","IBBQ","BK1583","688331","LNGR","LU1064130708.USD","KCAI","VXUS","BK1574","BK0239","BK1593","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672271376","title":"Akeso (SEHK:9926) Could Be 31% Undervalued As Phase III Trial Hits Key Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672271376","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672271376?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:18","pubTimestamp":1790925532,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) just put fresh clinical data at the center of its story. The company reported that its Phase III HARMONi-GI1 trial for advanced biliary tract cancer hit key survival goals.\nAkeso shares have reacted quickly to the HARMONi-GI1 headlines, with a 1-day share price return of 2.26% and a 7-day move of 15.76%. This has built on a 30-day gain of 26.91%, yet the shares are still sitting on a year-to-date share price decline of 4.06% and a 1-year total shareholder return down 22.25%...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-31-undervalued-as-phase-iii-trial-hi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-31-undervalued-as-phase-iii-trial-hi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2476274720.SGD","IE00B5MMRT66.SGD","LU0634319403.HKD","LU0348783233.USD","LU0348735423.USD","LU1794554557.SGD","LU0348784397.USD","BK1574","LU0348766576.USD","09926","IE00B543WZ88.USD","LU2778985437.USD","KURE","LU0417516738.SGD","LU1720050803.USD","LU0417516902.SGD","LU0348827113.USD","LU2488822045.USD","LU0348767384.USD","LU2399975544.HKD","LU0417516571.SGD","LU0561508036.HKD","BK1161","LU1961090484.USD","LU0348825331.USD","IE00BPRC5H50.USD","LU0540923850.HKD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672475774","title":"Does Long Term Trial Data Change The Bull Case For RemeGen Stock (SEHK:9995)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672475774","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672475774?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:12","pubTimestamp":1790849562,"startTime":"0","endTime":"0","summary":"Vor Bio reported a post hoc analysis of RemeGen partner trial data in adults with generalized myasthenia gravis, showing that telitacicept produced deep, durable minimal symptom expression over 48 weeks with no new safety signals in a 114-patient Phase 3 study in China.\nThe analysis suggests telitacicept could matter commercially for RemeGen, with around 42% of treated participants achieving minimal symptom expression and many sustaining it over time, including those who started with higher...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/does-long-term-trial-data-change-the-bull-case-for-remegen-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/does-long-term-trial-data-change-the-bull-case-for-remegen-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2328871848.SGD","LU1969619763.USD","09995","BK1583","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169719280","title":"October Golden Stock Picks from Brokerages Revealed, Covering Pharmaceuticals, Information Technology, and More; WuXi AppTec and Zhongji Innolight Receive the Most Recommendations (List)","url":"https://stock-news.laohu8.com/highlight/detail?id=1169719280","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169719280?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:40","pubTimestamp":1790847626,"startTime":"0","endTime":"0","summary":"For stock trading, check the Golden Qilin analyst research reports — authoritative, professional, timely, and comprehensive, helping you uncover potential thematic opportunities! WuXi AppTec is the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910500.SGD","IE00B5MMRT66.SGD","LU1580142542.USD","LU1808992512.USD","LU1934453819.USD","LU0540923850.HKD","LU0052750758.USD","LU0348767384.USD","LU1064131003.USD","LU1720050803.USD","LU1961090484.USD","LU1794554557.SGD","LU0531971595.HKD","BK1149","LU2289578879.USD","BK0070","LU0359201612.USD","LU0871576103.HKD","159938","BK1122","LU0700851271.USD","BK0028","LU0469268626.HKD","LU0456842615.SGD","LU2476274720.SGD","LU0359201885.HKD","LU1303224171.USD","LU0164939612.USD","159939","LU1255011170.USD","09939","IE00BYTNYN87.SGD","LU0348827113.USD","LU0327786744.USD","BK1249","LU2778985437.USD","IE0032431581.USD","HK0000306685.HKD","LU2476274308.USD","BK0216","LU1997245177.USD","LU0561508036.HKD","LU1770034418.SGD","BK1515","LU2213484517.USD","LU1969619763.USD","LU0611395673.USD","03308","LU0359202008.SGD","LU0572944931.SGD","LU0620787316.HKD","LU1719994722.HKD","LU1820825898.SGD","IE00B12V2V27.USD","LU1064130708.USD","LU2177674079.SGD","LU0417516738.SGD","HK0000306701.USD","LU0082770016.SGD","LU0348735423.USD","LU2580892789.USD","LU0634319403.HKD","IE00BPRC5H50.USD","LU0051755006.USD","LU0231483743.USD","LU2045819591.USD","BK0214","BK4585","BK1533","02359","LU1979443071.USD","LU1997244956.HKD","BK1574","LU2580892862.HKD","BK4588","LU0417516902.SGD","IE0034224299.USD","LU2008162690.USD","LU1655091616.SGD","HK0000320223.HKD","LU2488822045.USD","300308","LU0082770016.USD","ARKG","BK1576","LU0320764599.SGD","LU1206782309.USD","BK4544","LU2242644610.SGD","BK0077","603259","LU1146622755.USD","LU1023057109.AUD","91530","VGT","LU0039217434.USD","LU0456827905.SGD","LU1251922891.USD","LU1781817850.SGD","LU1046422090.SGD","IE00BYQNZ168.SGD","LU0348825331.USD","LU2328871848.SGD","KCE","LU2495084118.USD","SGXZ81163826.USD","LU0210526637.USD","LU0164865239.USD","LU0348766576.USD","BK1161","HK0000320264.USD","IE00B543WZ88.USD","LU2148510915.USD","LU1997245094.SGD","BK0167","BK1141","SGXZ49509284.SGD","LU2399975544.HKD","SG9999011746.SGD","BK1583","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151237778","title":"AH Premium Statistics: October 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1151237778","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151237778?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:21","pubTimestamp":1790842887,"startTime":"0","endTime":"0","summary":"As of the close on October 1, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) ranked as the top three in AH premium rates, at 1155.81%, 390.84%, and 336.74% respectively.CATL...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0488056044.USD","00699","03188","LU1048596156.SGD","LU0049853897.USD","LU0359201885.HKD","LU1720050803.USD","LU0164880469.USD","LU0329678170.USD","LU0320764755.SGD","BK1170","IE00B031J352.USD","02359","LU0345780521.USD","LU0708995583.HKD","LU1960683339.HKD","03750","BK1148","LU2476274308.USD","LU0449509016.USD","LU0828238088.HKD","83188","LU2177674079.SGD","LU1008478684.HKD","LU0348816934.USD","LU0096374516.USD","LU2097828631.EUR","LU0043850808.USD","LU0543330566.HKD","LU1244550577.SGD","LU1226287529.USD","LU2399975544.HKD","LU0320764599.SGD","HK0000320223.HKD","LU1504937902.USD","LU0067412154.USD","LU0456846285.SGD","BK1181","LU0327786744.USD","BK1505","LU0672654166.SGD","LU1719994722.HKD","BK1198","LU0326950275.SGD","BK1562","LU0516423091.SGD","LU2242644610.SGD","BK1149","LU2476274720.SGD","LU0149534421.HKD","159982","LU1188198961.HKD","BK1191","BK1147","LU0266512473.USD","LU0048580855.USD","BK1576","HK0000352382.USD","LU0229945570.USD","82843","LU0348767384.USD","LU0828237940.HKD","LU1206782309.USD","LU1675838814.USD","IE00B031HY20.USD","03328","BK1594","LU0117841782.USD","IE00B29SXG58.USD","LU1993786604.SGD","LU0828237510.HKD","LU1282649067.USD","IE00BZ08YR35.GBP","LU0348825331.USD","IE0031814852.USD","BK1237","LU0165289439.USD","LU1251922891.USD","LU0173614495.USD","BK1515","BK1130","BK1546","LU0417516902.SGD","LU0737861699.HKD","LU0181495838.USD","02218","LU0163747925.USD","LU0345780281.USD","LU1242518857.USD","LU0244354667.USD","IE00BZ08YS42.EUR","LU0509642566.USD","00991","00568","02822","LU1303224171.USD","BK1583","LU0417516738.SGD","SG9999004220.SGD","LU1244550221.USD","LU0328353924.USD","02899","LU1880383366.USD","SG9999001226.SGD","LU0648948544.HKD","82846","LU0823426480.USD","LU1105468828.SGD","IE00BF5LJ272.USD","HK0000252160.HKD","LU0287142896.SGD","LU0329678337.USD","LU2097828805.USD","LU0791591158.USD","HK0000306685.HKD","HK0000320264.USD","BK1202","LU0871576103.HKD","BK1183","SG9999002463.SGD","02691","LU1244550494.USD","BK1190","LU1064131342.USD","06067","LU0164939612.USD","03996","LU0979878070.USD","02827","LU0531971595.HKD","LU1808992512.USD","LU0082770016.SGD","BK1554","BK1249","IE00BVYPNQ40.USD","LU1242518931.SGD","LU0791590937.USD","LU2097828557.USD","HK0001040168.HKD","IE00B3M56506.USD","399300","LU0516423174.USD","LU0072913022.USD","LU0502904849.HKD","06821","07233","LU0370786039.SGD","BK1105","LU0823040885.USD","LU0266512127.USD","BK1231","LU0918141887.USD","SG9999001093.SGD","IE00BYV24P56.USD","LU0214875030.USD","BK1193","LU0315179316.USD","LU0348766576.USD","LU0543330483.HKD","03678","LU0051755006.USD","HK0000500386.USD","LU0128522157.USD","LU0449515922.USD","LU1794554557.SGD","LU1115378108.SGD","LU0589944569.HKD","LU0540923850.HKD","LU0348735423.USD","LU0149721374.USD","BK1100","BK1564","BK1122","LU2045819591.USD","LU2097828714.EUR","EWH","LU0607220059.USD","LU0797268264.HKD","LU1807302812.USD","LU0862451753.SGD","LU0348814723.USD","00916","LU0231483743.USD","LU0082770016.USD","LU2125910500.SGD","LU0106959298.USD","LU1282648689.USD","LU3063872942.SGD","SG9999011746.SGD","82822","BK1119","LU0254981946.USD","LU1988902786.USD","02245","LU0823426308.USD","BK1144","LU0061477393.USD","BK1507","06185","LU0054450605.USD","SG9999014674.SGD","IE00BMCWC346.EUR","LU2226246903.HKD","82823","LU1366334578.USD","BK1574","00553","09976","LU0620787316.HKD","02865","IE0032431581.USD","LU0588546209.SGD","LU0455707207.USD","LU0029875118.USD","LU1769817096.USD","LU0269904917.USD","BK1610","LU0463099449.HKD","LU1282649141.HKD","03986","LU1224709979.USD","BK1223","HK0000252152.HKD","LU1255011170.USD","BK1125","LU0052750758.USD","LU0039217434.USD","02846","BK1522","BK1141","LU0918141705.HKD","LU0561508036.HKD","BK1592","02238","LU1152091168.USD","LU0880133367.SGD","HK0000306701.USD","LU1655091616.SGD","LU1770034418.SGD","LU1046422090.SGD","SG9999002828.SGD","BK1539","00317","LU0456854461.SGD","LU0516422952.EUR","LU1769817179.HKD","IE00BVYPNP33.GBP","BK1163","LU2778985437.USD","LU0890818403.SGD","BK1161","LU0384037296.USD","LU0456827905.SGD","LU0572944931.SGD","LU0469268626.HKD","LU1023057109.AUD","LU1481107354.HKD","LU0431992006.USD","02338","03200","LU0228659784.USD","LU2008162690.USD","BK1116","LU0868486357.SGD","02843","06951","BK1551","BK1530","BK1521","IE0034224299.USD","LU0821914370.USD","BK1154","LU0307460666.USD","BK1514","03308","LU0640798160.USD","02823","IE0008368742.USD","LU0164865239.USD","LU0737861772.HKD","LU0348805143.USD","06127","LU0501845795.SGD","00811","LU2039709279.SGD","03130","HK0000352291.HKD","LU0634319403.HKD","IE00BGHQDM52.EUR","HK0001040143.USD","LU1813983027.USD","LU2294711473.HKD","BK1533","01033","LU1961090484.USD","IE0008369823.USD","LU0228367735.SGD","LU0531970944.HKD","01187","LU0348827113.USD","02475","01349","LU0516422440.USD","LU1211504680.USD","SG9999006597.SGD","BK1544","BK1110","LU0314109678.HKD","LU1688375341.USD","01108","00042","LU0211977185.USD","LU0593848301.USD","BK1558","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1880383440.USD","LU0516422366.SGD","BK1560","LU1366334651.USD","LU2097828474.EUR","LU0886674414.USD","01812","03143","LU0140636845.USD","BK1171","83130","LU0210526637.USD","03968","LU0359201612.USD","LU1328277881.USD","IE00B543WZ88.USD","LU0348788117.USD","LU0359202008.SGD","LU1152091754.HKD","LU2264538146.SGD","LU1831875114.USD","LU0106252389.USD","01057","LU1282649810.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755958","title":"Everest Medicines Stock In Focus After China Approval For CARDAMYST","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755958","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755958?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:17","pubTimestamp":1790842633,"startTime":"0","endTime":"0","summary":"Everest Medicines has secured NMPA approval in China for CARDAMYST, a self-administered etripamil nasal spray for acute PSVT episodes, supported by multiple studies showing rapid rhythm conversion, at-home use, and generally mild side effects.\nThe launch of CARDAMYST as Everest Medicines' first cardiovascular therapy moves the business into a new treatment area with a large PSVT and AFib RVR patient pool across Greater China.\nWe will now look at how Everest Medicines' investment narrative...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-stock-in-focus-after-china-approval-for-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-stock-in-focus-after-china-approval-for-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","MDCO","BK1574","01952","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118846740","title":"Two Active Equity Funds Double Returns Exceeding 110%! First Three Quarters Active Equity Fund Performance Rankings Released","url":"https://stock-news.laohu8.com/highlight/detail?id=1118846740","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118846740?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:20","pubTimestamp":1790832030,"startTime":"0","endTime":"0","summary":"Technology stocks pulled back from highs, pharmaceutical stocks staged a strong rally, and the number of 'double-return funds' shrank significantly.The first three quarters of A-share trading have...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","BK1161","09939","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124333888","title":"Pre-Holiday Gains: Can This Strong Sector Keep Rising After the Break?","url":"https://stock-news.laohu8.com/highlight/detail?id=1124333888","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124333888?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:11","pubTimestamp":1790777476,"startTime":"0","endTime":"0","summary":"On September 30, the final trading day before the National Day holiday, A-shares staged a session of \"stable index but internal divergence.\" Throughout the day, the Shanghai Composite Index rose...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","06978","BK1161","BK1574","MEDX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193254159","title":"China Pharma Sector Divergence Deepens as Innovative Drug Leaders Ride BD Second Growth Curve","url":"https://stock-news.laohu8.com/highlight/detail?id=1193254159","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193254159?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:30","pubTimestamp":1790775022,"startTime":"0","endTime":"0","summary":"China's pharmaceutical sector is undergoing a structural revaluation.Under the dual pressures of ongoing anti-corruption campaigns and medical insurance cost containment, domestic drugmakers saw...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","BK1161","09939","IBBQ","BK1574","MEDX","159938","159992","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184326594","title":"Guo Huaqing Steps Down as Non-Executive Director of CARsgen-B (02171)","url":"https://stock-news.laohu8.com/highlight/detail?id=1184326594","media":"Stock News","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184326594?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:08","pubTimestamp":1790773704,"startTime":"0","endTime":"0","summary":"CARsgen-B (02171) has announced that Mr. Guo Huaqing has tendered his resignation as a non-executive director of the company.The resignation will take effect on September 30, 2026.The company stated...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","BK1574","BK1585","02171"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":156,"code":"91000000","status":"200"}]}}